Alexion to Buy Wilson Therapeutics for $855 Million

16.04.2018 - US drugmaker Alexion Pharmaceuticals has offered to buy Sweden’s Wilson Therapeutics in a deal worth approximately $855 million. Stockholm-based Wilson develops novel therapies for...